![Xiao-Yi Xiao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao-Yi Xiao
Nessuna posizione attualmente
Profilo
Xiao-Yi Xiao worked as a Senior Director of Discovery Chemistry at Syrrx, Inc. and Miikana Therapeutics, Inc. He also worked as a Principal at Discovery Partners International, Inc. and Affymax Research Institute.
Additionally, he served as the Vice President of Medicinal Chemistry at Tetraphase Pharmaceuticals, Inc. Dr. Xiao holds a doctorate degree from Stony Brook University and an undergraduate degree from Sun Yat-Sen University.
Precedenti posizioni note di Xiao-Yi Xiao
Società | Posizione | Fine |
---|---|---|
Discovery Partners International, Inc.
![]() Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Corporate Officer/Principal | - |
Affymax Research Institute
![]() Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Corporate Officer/Principal | - |
Miikana Therapeutics, Inc.
![]() Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Syrrx, Inc.
![]() Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Portfolio Manager-Fixed Income | - |
TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Xiao-Yi Xiao
Sun Yat-Sen University | Undergraduate Degree |
Stony Brook University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Tetraphase Pharmaceuticals, Inc.
![]() Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Miikana Therapeutics, Inc.
![]() Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Health Technology |
Syrrx, Inc.
![]() Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Affymax Research Institute
![]() Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Commercial Services |
Discovery Partners International, Inc.
![]() Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Commercial Services |
- Borsa valori
- Insiders
- Xiao-Yi Xiao